In November 2016, PacBio filed a Complaint with the International Trade Commission (“ITC”) alleging that Oxford Nanopore infringed two of PacBio’s patents and seeking to prevent Oxford Nanopore from selling its product in the United States. Today, the ITC Commission has made a Final Determination affirming the Administrative Judge’s decision that Oxford Nanopore has not […]
Another New Year. Another new patent. Stratedigm’s latest patent granted by the United States Patent Office is the next leap forward in microparticle detection. It gives users the ability to measure both small and large particles all within one sample. It provides an industry-leading three decades of dynamic range off the SSC and FSC channels […]
BioAxial, a developer and seller of Conical Diffraction Microscopy (CODIM) technology, has been granted a US patent covering ‘black fluorophore’ technology, which will be included in the second generation of CODIM products. Black fluorophore is an important component of ‘dark tracking’ technology, which belongs to a new family of super resolution techs in microscopy that […]
New technology will be included in the second generation of CODIM products, providing access to single molecule tracking with true nanoscopic molecular resolution Paris, France – BioAxial, a key player in live cell super resolution microscopy, today announces that it has been granted a US patent covering ‘black fluorophore’, a pivotal component of ‘dark tracking’ technology. […]
SANTA CRUZ, Calif. — SomaGenics, an RNA-focused biotechnology company, expands its IP protection with three newly issued patents by the United States Patent and Trademark Office covering two of the Company’s core RNA detection technologies: targeted small RNA sequencing (RealSeq®-T) and quantitative PCR analysis of RNA fragments (ResQ®), as well as SomaGenics’ therapeutic sshRNA®s. A patent […]
Patent covers successful integration of an external DNA sequenceinto the chromosome of eukaryotic cells using CRISPR Fourth patent allowance for Merck’s CRISPR technology; similarpatents from Australian, Canadian and European Patent Officesalready received Merck to license its CRISPR-related patents to interested parties Merck, a leading science and technology company, today announced that the Intellectual Property Office […]
CAMBRIDGE, England CS Genetics Limited, a developer of tools and techniques for genomics, was granted its first patent (GB 2,539,675 B) on 22 November 2017. CS Genetics is developing Coding Strand Sequencing™: a platform for instrument-free, solution-phase indexing of nucleic acids. Coding Strand Sequencing™ uses a new class of macromolecular indexing tool called Coding Strands™ to tag […]
Base4 is celebrating the grant of DNA sequencing patent US 9,771,615. This is our 8th granted patent family and our 25th granted patent, 22 of which have been granted over the past 3 years. Base4 is an IP rich company and our continued success underlines the degree to which our approach is novel and highly […]
DURHAM, N.C.—-Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the European Patent Office has issued EPO Patent Nos. 1581612 and 2719756 covering the design of Xona’s products used for neuroscientific and neurodegenerative disease research. Xona already holds the exclusive license to manufacture […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
